FDA re­names and re­struc­tures on­col­o­gy of­fice

The FDA’s of­fice re­spon­si­ble for ap­prov­ing can­cer ther­a­pies has been re­named the Of­fice of On­co­log­ic Dis­eases (OOD) and re­struc­tured to add new di­vi­sions, the agency …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER